Cubist Systematic Strategies’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Cubist Systematic Strategies’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-254,846	Closed	-$2.66M	–	4599
2023 Q1	$2.66M	Sell	254,846 -36,617	-13%	-$379K	0.02%	1437
2022 Q4	$2.97M	Sell	291,463 -2	-0%	-$20	0.02%	1484
2022 Q3	$2.92M	Buy	291,465 +23,885	+9%	+$239K	0.02%	1617
2022 Q2	$2.67M	Buy	267,580 +11,023	+4%	+$110K	0.02%	1571
2022 Q1	$2.56M	Buy	+256,557	New	+$2.55M	0.02%	1275

Cubist Systematic Strategies's LVAC Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 254,846 shares — an estimated $2.66M sold.

Cubist Systematic Strategies first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $2.97M in Q4 2022. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Cubist Systematic Strategies reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 254,846 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.66M.
Cubist Systematic Strategies first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Cubist Systematic Strategies's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.97M in Q4 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.